Correlation Between Direct Line and Lion Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Direct Line and Lion Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Direct Line and Lion Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Direct Line Insurance and Lion Biotechnologies, you can compare the effects of market volatilities on Direct Line and Lion Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Direct Line with a short position of Lion Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Direct Line and Lion Biotechnologies.

Diversification Opportunities for Direct Line and Lion Biotechnologies

-0.53

Correlation Coefficient

Direct Line  Lion Biotechnologies

Excellent diversification

The 3 months correlation between Direct and Lion is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Direct Line Insurance and Lion Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lion Biotechnologies and Direct Line is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Direct Line Insurance are associated (or correlated) with Lion Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lion Biotechnologies has no effect on the direction of Direct Line i.e., Direct Line and Lion Biotechnologies go up and down completely randomly.

Pair Corralation between Direct Line and Lion Biotechnologies

Assuming the 90 days trading horizon Direct Line is expected to generate 1.05 times less return on investment than Lion Biotechnologies. But when comparing it to its historical volatility, Direct Line Insurance is 1.69 times less risky than Lion Biotechnologies. It trades about 0.04 of its potential returns per unit of risk. Lion Biotechnologies is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  738.00  in Lion Biotechnologies on September 27, 2024 and sell it today you would lose (30.00) from holding Lion Biotechnologies or give up 4.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Direct Line Insurance  vs.  Lion Biotechnologies

Direct Line Insurance

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Direct Line Insurance are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Direct Line reported solid returns over the last few months and may actually be approaching a breakup point.

Lion Biotechnologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Direct Line and Lion Biotechnologies

The main advantage of trading using opposite Direct Line and Lion Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Direct Line position performs unexpectedly, Lion Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lion Biotechnologies will offset losses from the drop in Lion Biotechnologies' long position.

The idea behind Direct Line Insurance and Lion Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.